CareDx, Inc. (CDNA) shares surged 27.97 percent to $22.48, gaining $4.91 on Thursday likely driven by yesterday's announcement of $170 million divestiture agreement and strong preliminary first-quarter results.
The stock is currently trading at $22.48, up from its previous close of $17.57 on the Nasdaq. It opened at $21.12 and has traded in a range of $20.10 to $22.38 during the session, with volume reaching 1.13 million shares compared to an average of 630,410 shares.
The company announced it will sell its Lab Products business to EuroBio Scientific for $170 million in cash, aiming to streamline operations and focus on its core precision medicine business. CareDx also reported preliminary first quarter revenue of approximately $118 million, up 39 percent year-over-year.
The 52-week range for the stock is $10.96 to $22.38.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.